References

• 2009Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement84,364 cited
• 2009Preferred reporting items for systematic reviews and meta-analyses: the PRISMA Statement.48,853 cited
• 2005Lifetime Prevalence and Age-of-Onset Distributions of DSM-IV Disorders in the National Comorbidity Survey Replication20,388 cited
• 2009Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement19,875 cited
• 1994Lifetime and 12-Month Prevalence of DSM-III-R Psychiatric Disorders in the United States12,377 cited
• 2005Prevalence and Treatment of Mental Disorders, 1990 to 20031,911 cited
• 2004Prevalence, co-morbidity and correlates of mental disorders in the general population: results from the German Health Interview and Examination Survey (GHS)1,097 cited
• 2008World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for the Pharmacological Treatment of Anxiety, Obsessive-Compulsive and Post-Traumatic Stress Disorders – First Revision862 cited
• 2014Psychische Störungen in der Allgemeinbevölkerung749 cited
• 2005Prevalence and Treatment of Mental Disorders650 cited
• 2005Evidence-based guidelines for the pharmacological treatment of anxiety disorders: recommendations from the British Association for Psychopharmacology630 cited
• 2002Generalized anxiety and depression in primary care: prevalence, recognition, and management.518 cited
• 2015Erratum zu: Psychische Störungen in der Allgemeinbevölkerung. Studie zur Gesundheit Erwachsener in Deutschland und ihr Zusatzmodul „Psychische Gesundheit“ (DEGS1-MH)